Breaking News Instant updates and real-time market news.

PUBGY

Publicis

$0.00 /

+ (+0.00%)

11:08
04/13/20
04/13
11:08
04/13/20
11:08

Publicis reports Q1 organic growth down 2.9%, no guidance given

Publicis Groupe's net revenue in Q1 was EUR 2.48B, up 17.1% from EUR 2.12B in 2019. Exchange rates had a positive impact of EUR 33M. Acquisitions, net of disposals, accounted for an increase in net revenue of EUR 393M, reflecting the contribution from Epsilon, and to a lesser extent Rauxa, partly offset by the disposal of PHS and Proximedia. "Organic growth stood at negative 2.9%, an encouraging number supported by the performance in the U.S and despite the impact of Covid-19," the company said. Arthur Sadoun, Chairman and CEO of Publicis Groupe, said, "It is slightly awkward to share encouraging news at a time when we are preparing ourselves for tougher days. But we actually had a good start to the year, meeting our internal objectives despite the impact of Covid-19, with an organic growth at -2.9%. At the end of February before the pandemic started to spread, we recorded almost flat growth, despite double-digit decline in China, mostly driven by 5% organic growth in the U.S. on our creative and media business. It is worth noting that Epsilon 2.0 was also growing at +5% growth at the end of February. The month of March was seriously affected by the continuous decline in China and the abrupt deterioration in Europe, due to Covid-19 confinement measures. This strong negative impact was largely compensated by North America returning to growth, including Publicis Sapient which is slightly positive in the US. This performance demonstrates that our model is working. But we are now all facing a crisis that will be unparalleled in terms of magnitude, complexity, and probably length. In these uncertain times, we haven't waited to define our three priorities. First and foremost, we have been focusing on protecting our people. We immediately acted to put in place the necessary infrastructure to enable all of our employees to work safely from home. We took a series of measures for their health and well-being, to keep everyone supported. We advanced the launch of our global AI platform Marcel, as it has never been so important to keep our teams across the world connected and fight the effects of isolation. Second, we have worked around the clock to help our clients adapt to this situation. We reviewed their current and future commercial and corporate messages. We realigned their media plans to be much more dynamic, deliver short-term ROI and proposed some outcome-based products we have developed for this new market context. We are also helping them accelerate their digital capabilities to drive growth and efficiencies. Last but not least, we are taking exceptional measures to face the coming recession and preserve a solid balance sheet. We are implementing a 500 million euro cost-reduction plan with full impact in 2020, to adapt and be recovery ready. We are asking our shareholders for solidarity with our company and our people by cutting dividends by 50% and exceptionally delaying payment until the end of September. At the same time, the Groupe's management team has decided to reduce its fixed remuneration. There is no doubt that we are going through an unprecedented health crisis that will lead us to the greatest recession in living memory. It is too early to predict the full impact it will have on our clients and our business, so we will not provide any guidance. All of our countries, all of our activities will be impacted to varying degrees. So our response to this situation needs to be structured, multi-faceted and rigorously executed. Our experience in managing cost and cash in times of crisis, our country model and our strong balance sheet will help us to stand firm in this storm and prepare ourselves for recovery."

PUBGY Publicis
$0.00 /

+ (+0.00%)

04/09/20 Societe Generale
Publicis upgraded to Buy from Hold yesterday at Societe Generale
03/23/20 Barclays
Publicis upgraded to Overweight from Equal Weight at Barclays
01/13/20 Goldman Sachs
Publicis upgraded to Buy from Neutral at Goldman Sachs
10/15/19 Berenberg
Publicis downgraded to Hold from Buy at Berenberg

TODAY'S FREE FLY STORIES

Recommendations
Crowdstrike price target raised to $193 from $170 at Barclays » 06:32
12/03/20
12/03
06:32
12/03/20
06:32
CRWD

Crowdstrike

$141.84 /

-5.65 (-3.83%)

Barclays analyst Saket…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

06:26 Today JMP Securities
Crowdstrike price target raised to $180 from $160 at JMP Securities
06:10 Today Piper Sandler
Crowdstrike price target raised to $180 from $175 at Piper Sandler
04:52 Today Jefferies
Crowdstrike price target raised to $160 from $150 at Jefferies
11/30/20 RBC Capital
Crowdstrike price target raised to $170 from $160 at RBC Capital
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

  • 26
    Jun
  • 07
    Jan
  • 09
    Dec
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

Syndicate
Shift4 Payments 8M share Secondary priced at $55.50 » 06:32
12/03/20
12/03
06:32
12/03/20
06:32
FOUR

Shift4 Payments

$56.02 /

-1.99 (-3.43%)

Goldman Sachs, Credit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$56.02 /

-1.99 (-3.43%)

FOUR Shift4 Payments
$56.02 /

-1.99 (-3.43%)

10/14/20 Truist
Shift4 Payments price target raised to $70 from $60 at Truist
10/14/20 Compass Point
Shift4 Payments upgraded to Neutral after pre-announcement at Compass Point
10/14/20 Compass Point
Shift4 Payments upgraded to Neutral from Sell at Compass Point
10/08/20 RBC Capital
Shift4 Payments price target raised to $63 from $49 at RBC Capital
FOUR Shift4 Payments
$56.02 /

-1.99 (-3.43%)

  • 03
    Dec
  • 11
    Sep
  • 05
    Jun
FOUR Shift4 Payments
$56.02 /

-1.99 (-3.43%)

FOUR Shift4 Payments
$56.02 /

-1.99 (-3.43%)

Recommendations
Lyft price target raised to $50 from $44 at JMP Securities » 06:30
12/03/20
12/03
06:30
12/03/20
06:30
LYFT

Lyft

$43.44 /

+3.82 (+9.64%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$43.44 /

+3.82 (+9.64%)

LYFT Lyft
$43.44 /

+3.82 (+9.64%)

12/01/20 Loop Capital
Lyft price target raised to $50 from $41 at Loop Capital
11/12/20 DA Davidson
Lyft price target raised to $42 from $37 at DA Davidson
11/11/20 Jefferies
Lyft price target raised to $45 from $40 at Jefferies
11/11/20 RBC Capital
Lyft price target lowered to $46 from $48 at RBC Capital
LYFT Lyft
$43.44 /

+3.82 (+9.64%)

LYFT Lyft
$43.44 /

+3.82 (+9.64%)

LYFT Lyft
$43.44 /

+3.82 (+9.64%)

LYFT Lyft
$43.44 /

+3.82 (+9.64%)

Recommendations
Okta price target raised to $295 from $266 at Citi » 06:29
12/03/20
12/03
06:29
12/03/20
06:29
OKTA

Okta

$230.12 /

-6.76 (-2.85%)

Citi analyst Walter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

06:16 Today Piper Sandler
Okta price target raised to $250 from $225 at Piper Sandler
11/23/20 KeyBanc
Okta initiated with an Overweight at KeyBanc
10/15/20 Mizuho
Okta price target raised to $255 from $245 at Mizuho
10/08/20 RBC Capital
Okta price target raised to $255 from $235 at RBC Capital
OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

Syndicate
Silverback Therapeutics IPO size to 10M shares, price range to $19.00-$20.00 » 06:28
12/03/20
12/03
06:28
12/03/20
06:28
SBTX

Silverback Therapeutics

$0.00 /

+ (+0.00%)

Silverback Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 04
    Dec
Recommendations
XPO Logistics price target raised to $138 from $120 at Citi » 06:28
12/03/20
12/03
06:28
12/03/20
06:28
XPO

XPO Logistics

$110.00 /

-0.45 (-0.41%)

Citi analyst Christian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

11/30/20 Deutsche Bank
XPO Logistics price target raised to $136 from $115 at Deutsche Bank
11/10/20 Truist
XPO Logistics price target raised to $118 from $92 at Truist
11/09/20 Credit Suisse
XPO Logistics price target raised to $114 from $108 at Credit Suisse
11/09/20 Oppenheimer
XPO Logistics price target raised to $108 from $103 at Oppenheimer
XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

Hot Stocks
DPW Holdings to acquire 9.9% equity interest in Universal Security Instruments » 06:26
12/03/20
12/03
06:26
12/03/20
06:26
DPW

DPW Holdings

$4.50 /

-0.04 (-0.88%)

, UUU

Universal Security Instruments

$3.10 /

+0.07 (+2.31%)

DPW Holdings (DPW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DPW DPW Holdings
$4.50 /

-0.04 (-0.88%)

UUU Universal Security Instruments
$3.10 /

+0.07 (+2.31%)

DPW DPW Holdings
$4.50 /

-0.04 (-0.88%)

Recommendations
iRhythm price target lowered to $238 from $275 at Citi » 06:26
12/03/20
12/03
06:26
12/03/20
06:26
IRTC

iRhythm

$192.06 /

-48.59 (-20.19%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$192.06 /

-48.59 (-20.19%)

IRTC iRhythm
$192.06 /

-48.59 (-20.19%)

12/02/20 William Blair
iRhythm fundamentals strong, but reimbursement an overhang, says William Blair
12/02/20 Morgan Stanley
iRhythm price target lowered to $230 from $270 at Morgan Stanley
12/02/20 JPMorgan
iRhythm 25% selloff would be 'aggressive' buying opportunity, says JPMorgan
12/02/20 Citi
Final CMS rates surprising, created confusion around iRhythm, says Citi
IRTC iRhythm
$192.06 /

-48.59 (-20.19%)

  • 19
    Aug
IRTC iRhythm
$192.06 /

-48.59 (-20.19%)

Recommendations
Crowdstrike price target raised to $180 from $160 at JMP Securities » 06:26
12/03/20
12/03
06:26
12/03/20
06:26
CRWD

Crowdstrike

$141.84 /

-5.65 (-3.83%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

06:10 Today Piper Sandler
Crowdstrike price target raised to $180 from $175 at Piper Sandler
04:52 Today Jefferies
Crowdstrike price target raised to $160 from $150 at Jefferies
11/30/20 RBC Capital
Crowdstrike price target raised to $170 from $160 at RBC Capital
11/30/20 Needham
Crowdstrike price target raised to $190 from $170 at Needham
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

  • 26
    Jun
  • 07
    Jan
  • 09
    Dec
CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

CRWD Crowdstrike
$141.84 /

-5.65 (-3.83%)

Syndicate
Array Technologies 31.875M share Secondary priced at $35.00 » 06:26
12/03/20
12/03
06:26
12/03/20
06:26
ARRY

Array Technologies

$37.65 /

-3.05 (-7.49%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARRY Array Technologies
$37.65 /

-3.05 (-7.49%)

ARRY Array Technologies
$37.65 /

-3.05 (-7.49%)

11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Morgan Stanley
Array Technologies initiated with an Underweight at Morgan Stanley
11/09/20 UBS
Array Technologies initiated with a Neutral at UBS
11/09/20 Oppenheimer
Array Technologies initiated with a Perform at Oppenheimer
  • 03
    Dec
  • 15
    Oct
ARRY Array Technologies
$37.65 /

-3.05 (-7.49%)

ARRY Array Technologies
$37.65 /

-3.05 (-7.49%)

Syndicate
Dada Nexus 9M share Spot Secondary priced at $50.00 » 06:24
12/03/20
12/03
06:24
12/03/20
06:24
DADA

Dada Nexus

$53.70 /

-2.55 (-4.53%)

Goldman Sachs, BofA,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DADA Dada Nexus
$53.70 /

-2.55 (-4.53%)

DADA Dada Nexus
$53.70 /

-2.55 (-4.53%)

11/11/20
Fly Intel: Top five analyst upgrades
11/11/20 Goldman Sachs
Goldman Sachs upgrades Dada Nexus to Buy on online grocery adoption in China
11/11/20 Goldman Sachs
Dada Nexus upgraded to Buy from Neutral at Goldman Sachs
10/29/20 New Street
Dada Nexus initiated with a Buy at New Street
DADA Dada Nexus
$53.70 /

-2.55 (-4.53%)

  • 03
    Dec
  • 05
    Jun
DADA Dada Nexus
$53.70 /

-2.55 (-4.53%)

Upgrade
Henkel upgraded to Overweight from Neutral at JPMorgan » 06:24
12/03/20
12/03
06:24
12/03/20
06:24
HENKY

Henkel

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HENKY Henkel
$0.00 /

+ (+0.00%)

11/30/20 Commerzbank
Henkel upgraded to Buy from Hold at Commerzbank
10/14/20 Kepler Cheuvreux
Henkel upgraded to Hold from Reduce at Kepler Cheuvreux
10/14/20 Kepler Cheuvreux
Henkel upgraded to Hold from Reduce at Kepler Cheuvreux
10/13/20 Berenberg
Henkel price target raised to EUR 92 from EUR 85 at Berenberg
Upgrade
Sabra Health Care upgraded to Outperform from Market Perform at JMP Securities » 06:23
12/03/20
12/03
06:23
12/03/20
06:23
SBRA

Sabra Health Care

$17.23 /

+0.16 (+0.94%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBRA Sabra Health Care
$17.23 /

+0.16 (+0.94%)

SBRA Sabra Health Care
$17.23 /

+0.16 (+0.94%)

05:10 Today JMP Securities
Sabra Health Care upgraded to Outperform from Market Perform at JMP Securities
10/02/20 Mizuho
Sabra Health Care price target raised to $16 from $14 at Mizuho
09/01/20 Stifel
Sabra Health Care resumed with a Hold at Stifel
07/02/20 Citi
Sabra Health Care price target raised to $14 from $10 at Citi
SBRA Sabra Health Care
$17.23 /

+0.16 (+0.94%)

Downgrade
Danone downgraded to Neutral from Overweight at JPMorgan » 06:22
12/03/20
12/03
06:22
12/03/20
06:22
DANOY

Danone

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DANOY Danone
$0.00 /

+ (+0.00%)

DANOY Danone
$0.00 /

+ (+0.00%)

11/30/20 Morgan Stanley
Danone price target raised to EUR 58 from EUR 54 at Morgan Stanley
11/25/20 JPMorgan
Danone price target lowered to EUR 66 from EUR 73 at JPMorgan
10/29/20 UBS
Danone price target lowered to EUR 45 from EUR 52.50 at UBS
10/21/20 Berenberg
Danone price target lowered to EUR 59 from EUR 61.50 at Berenberg
DANOY Danone
$0.00 /

+ (+0.00%)

DANOY Danone
$0.00 /

+ (+0.00%)

Syndicate
XP Inc. 31.655M share Secondary priced at $39.00 » 06:21
12/03/20
12/03
06:21
12/03/20
06:21
XP

XP Inc.

$40.34 /

-0.03 (-0.07%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XP XP Inc.
$40.34 /

-0.03 (-0.07%)

XP XP Inc.
$40.34 /

-0.03 (-0.07%)

10/16/20
Fly Intel: Top five analyst upgrades
10/16/20 BofA
XP Inc. upgraded to Neutral from Underperform at BofA
10/16/20 BofA
XP Inc. upgraded to Neutral from Underperform at BofA
06/24/20 Credit Suisse
XP Inc. downgraded to Underperform from Neutral at Credit Suisse
XP XP Inc.
$40.34 /

-0.03 (-0.07%)

  • 03
    Dec
  • 02
    Jul
  • 11
    Dec
Downgrade
Amundi downgraded to Neutral from Buy at Citi » 06:19
12/03/20
12/03
06:19
12/03/20
06:19
AMDUF

Amundi

$0.00 /

+ (+0.00%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMDUF Amundi
$0.00 /

+ (+0.00%)

11/02/20 Morgan Stanley
Amundi price target lowered to EUR 71 from EUR 72.40 at Morgan Stanley
10/26/20 Deutsche Bank
Amundi price target raised to EUR 72 from EUR 70 at Deutsche Bank
10/09/20 Morgan Stanley
Amundi price target lowered to EUR 72.40 from EUR 76.30 at Morgan Stanley
10/09/20 Credit Suisse
Amundi upgraded to Outperform from Neutral at Credit Suisse
Upgrade
Omega Healthcare upgraded to Outperform from Market Perform at JMP Securities » 06:19
12/03/20
12/03
06:19
12/03/20
06:19
OHI

Omega Healthcare

$36.84 /

+0.45 (+1.24%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$36.84 /

+0.45 (+1.24%)

OHI Omega Healthcare
$36.84 /

+0.45 (+1.24%)

05:07 Today JMP Securities
Omega Healthcare upgraded to Outperform from Market Perform at JMP Securities
11/30/20
Fly Intel: Top five analyst upgrades
11/30/20 BofA
Omega Healthcare double-upgraded to Buy from Underperform at BofA
11/30/20 BofA
Omega Healthcare upgraded to Buy from Underperform at BofA
OHI Omega Healthcare
$36.84 /

+0.45 (+1.24%)

Hot Stocks
Arrow Electronics signs multi-year partnership extension with McLaren Racing » 06:19
12/03/20
12/03
06:19
12/03/20
06:19
ARW

Arrow Electronics

$93.61 /

+0.87 (+0.94%)

Arrow Electronics has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARW Arrow Electronics
$93.61 /

+0.87 (+0.94%)

ARW Arrow Electronics
$93.61 /

+0.87 (+0.94%)

10/30/20 Citi
Arrow Electronics price target raised to $85 from $75 at Citi
07/13/20 Citi
Analog/Maxim deal positive for Arrow Electronics, negative for Avnet, says Citi
06/25/20 Longbow
Longbow cuts second half estimates for semis and components
04/28/20 BofA
Arrow Electronics upgraded to Neutral from Underperform at BofA
ARW Arrow Electronics
$93.61 /

+0.87 (+0.94%)

Syndicate
Progenity 7.645M share Secondary priced at $3.60 » 06:18
12/03/20
12/03
06:18
12/03/20
06:18
PROG

Progenity

$3.29 /

-0.35 (-9.62%)

Piper Sandler and Wells…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PROG Progenity
$3.29 /

-0.35 (-9.62%)

PROG Progenity
$3.29 /

-0.35 (-9.62%)

11/10/20 Piper Sandler
Progenity price target lowered to $15 from $17 at Piper Sandler
10/29/20 Piper Sandler
Piper Sandler still likes Progenity despite 'spooky' Q3 miss
10/23/20 BTIG
Progenity initiated with a Buy at BTIG
09/25/20 Piper Sandler
Progenity shares remain undervalued, says Piper Sandler
PROG Progenity
$3.29 /

-0.35 (-9.62%)

  • 03
    Dec
  • 19
    Jun
PROG Progenity
$3.29 /

-0.35 (-9.62%)

Downgrade
AIB Group downgraded to Neutral from Buy at Citi » 06:18
12/03/20
12/03
06:18
12/03/20
06:18
AIBRF

AIB Group

$0.00 /

+ (+0.00%)

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIBRF AIB Group
$0.00 /

+ (+0.00%)

11/24/20 Morgan Stanley
AIB Group price target raised to EUR 1.45 from EUR 1.30 at Morgan Stanley
10/21/20 Deutsche Bank
AIB Group resumed with a Buy at Deutsche Bank
10/06/20 Barclays
AIB Group upgraded to Overweight from Equal Weight at Barclays
09/03/20 UBS
AIB Group upgraded to Buy from Neutral at UBS
Syndicate
Kinnate Biopharma 12M share IPO priced at $20.00 » 06:18
12/03/20
12/03
06:18
12/03/20
06:18
KNTE

Kinnate Biopharma

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 03
    Dec
Recommendations
Semtech price target raised to $80 from $70 at Piper Sandler » 06:17
12/03/20
12/03
06:17
12/03/20
06:17
SMTC

Semtech

$67.71 /

-0.17 (-0.25%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMTC Semtech
$67.71 /

-0.17 (-0.25%)

SMTC Semtech
$67.71 /

-0.17 (-0.25%)

11/30/20 B. Riley Securities
Semtech price target raised to $83 from $72 at B. Riley Securities
11/25/20 Oppenheimer
Semtech price target raised to $75 from $65 at Oppenheimer
08/27/20 B. Riley FBR
Semtech price target raised to $72 from $65 at B. Riley FBR
08/27/20 Wells Fargo
Semtech price target raised to $67 from $57 at Wells Fargo
SMTC Semtech
$67.71 /

-0.17 (-0.25%)

SMTC Semtech
$67.71 /

-0.17 (-0.25%)

Upgrade
Square upgraded to Outperform from In Line at Evercore ISI » 06:16
12/03/20
12/03
06:16
12/03/20
06:16
SQ

Square

$202.11 /

-0.885 (-0.44%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$202.11 /

-0.885 (-0.44%)

SQ Square
$202.11 /

-0.885 (-0.44%)

11/25/20 Credit Suisse
Square price target raised to $210 from $200 at Credit Suisse
11/19/20 Morgan Stanley
Growth of Square's Cash App may be impacted by needed fixes, says Morgan Stanley
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/19/20 Mizuho
Square price target raised to $300 from $225 at Mizuho
SQ Square
$202.11 /

-0.885 (-0.44%)

SQ Square
$202.11 /

-0.885 (-0.44%)

SQ Square
$202.11 /

-0.885 (-0.44%)

SQ Square
$202.11 /

-0.885 (-0.44%)

Syndicate
Oak Street Health 5.63M share Secondary priced at $46.00 » 06:16
12/03/20
12/03
06:16
12/03/20
06:16
OSH

Oak Street Health

$49.00 /

+4.07 (+9.06%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSH Oak Street Health
$49.00 /

+4.07 (+9.06%)

OSH Oak Street Health
$49.00 /

+4.07 (+9.06%)

11/11/20 Piper Sandler
Oak Street Health price target raised to $59 from $54 at Piper Sandler
11/11/20 SVB Leerink
Oak Street Health price target raised to $78 from $55 at SVB Leerink
11/11/20 Baird
Oak Street Health price target raised to $60 from $55 at Baird
10/13/20 Truist
Truist raises price targets on select Healthcare Services names
OSH Oak Street Health
$49.00 /

+4.07 (+9.06%)

  • 03
    Dec
  • 06
    Aug
OSH Oak Street Health
$49.00 /

+4.07 (+9.06%)

OSH Oak Street Health
$49.00 /

+4.07 (+9.06%)

Recommendations
Okta price target raised to $250 from $225 at Piper Sandler » 06:16
12/03/20
12/03
06:16
12/03/20
06:16
OKTA

Okta

$230.12 /

-6.76 (-2.85%)

Piper Sandler analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

11/23/20 KeyBanc
Okta initiated with an Overweight at KeyBanc
10/15/20 Mizuho
Okta price target raised to $255 from $245 at Mizuho
10/08/20 RBC Capital
Okta price target raised to $255 from $235 at RBC Capital
10/08/20 BMO Capital
Okta price target raised to $260 from $228 at BMO Capital
OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

OKTA Okta
$230.12 /

-6.76 (-2.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.